We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial.
- Authors
Gilbert, Peter B; Peterson, Michael L; Follmann, Dean; Hudgens, Michael G; Francis, Donald P; Gurwith, Marc; Heyward, William L; Jobes, David V; Popovic, Vladimir; Self, Steven G; Sinangil, Faruk; Burke, Donald; Berman, Phillip W
- Abstract
An objective of the first efficacy trial of a candidate vaccine containing recombinant human immunodeficiency virus (HIV) type 1 envelope glycoprotein 120 (rgp120) antigens was to assess correlations between antibody responses to rgp120 and the incidence of HIV-1 infection.
- Publication
The Journal of infectious diseases, 2005, Vol 191, Issue 5, p666
- ISSN
0022-1899
- Publication type
Journal Article
- DOI
10.1086/428405